Milestone Scientific Appoints Marvin Terrell as Director of Domestic Distribution

LIVINGSTON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced the appointment of Marvin Terrell as Director of Domestic Distribution.  In this newly created position, Terrell is responsible for all facets of domestic distribution and marketing of Milestone's dental products in the United States and Canada.

"With an aim towards optimizing penetration of the domestic dental market, given Milestone's performance thus far in 2010, we now can establish a dedicated in-house resource capable of developing our domestic and Canadian markets," stated Leonard Osser, Milestone's Chief Executive Officer.  Continuing, he added, "In this regard, we have spent considerable time and effort to identify someone with the right blend of ambition, skill and industry experience necessary to man this new post and manage our marketing, sales and training efforts.  Marvin certainly meets all of our criteria and is expected to play an important role in Milestone's future success."

Prior to joining the Company, Terrell served as North American Director of Sales for OralCDx Laboratories, a division of Oral Cancer Prevention International, Inc., where he conceptualized and implemented sales and marketing strategies focused on increasing global market penetration for the BrushTest®, a quick and painless method that dentists use to detect oral cancer.  While serving as Vice President of Sales and New Business Development for Professional Dental Technologies, he managed day-to-day sales and business development activities for the Company's dental division, representing over $40 million in annual sales.  Previous senior management posts also included Manager, National Accounts, Medical Division at HPSC, Inc.; and Director of National Accounts and Medical Business Development at Old Kent Bank Leasing, Inc., where he dealt primarily with international companies with market capitalizations over $1 billion.  Early on in his 25-year career, he worked at Wells Fargo, initially serving as Director of Operations of the Company's Orlando, Florida business unit; followed by Corporate Retail Marketing Manager at its Consumer Division in Des Moines, Iowa; and later as Director of National Accounts, Leasing and Revolving Sales at Wells Fargo Leasing in O'Fallon, Missouri.  Terrell is a graduate of Valdosta State University, where he received a Bachelor of Fine Arts degree in Communications and Marketing.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled injection technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North America, Asia, Africa and Europe.  For more information on the STA Single Tooth Anesthesia System® unit and other innovative Milestone products, please visit the Company's web sites found at www.milestonescientific.com and www.STAis4U.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2009. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof.  Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

SOURCE Milestone Scientific Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED